Paradigm

Government of Canada invests $1.4 billion in strategic research at postsecondary institutions

Retrieved on: 
Friday, April 28, 2023

To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of our researchers.

Key Points: 
  • To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of our researchers.
  • Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced an investment of $1.4 billion in support for 11 large-scale research initiatives in strategic areas, through the Canada First Research Excellence Fund (CFREF).
  • This investment will allow researchers at Canadian institutions to capitalize on the strengths of their respective research areas, and attract capital and world-class talent.
  • —Ted Hewitt, Chair, Tri-agency Institutional Programs Secretariat Steering Committee; President, Social Sciences and Humanities Research Council of Canada; and Chair, Canada Research Coordinating Committee
    Created in 2014, CFREF supports Canadian postsecondary institutions in their efforts to become global research leaders.

Unum Group Releases 2022 ESG Report

Retrieved on: 
Friday, April 28, 2023

CHATTANOOGA, Tenn., April 28, 2023 /PRNewswire/ -- Unum's 2022 Environmental, Social, and Governance (ESG) report shows the company is reducing its environmental impact and building more inclusive communities for employees and customers.

Key Points: 
  • Unum's ongoing ESG work highlights how the company supports its corporate strategy, purpose, and values.
  • "Our approach of taking care of people at time of need drives our efforts to positively impact the world around us," said Rick McKenney, president and chief executive officer of Unum Group.
  • Helping Communities: Unum Group gave $12 million in corporate and employee contributions to charitable causes, while employees performed more than 45,000 volunteer hours.
  • In 2022, the company launched I&D training that explored personal biases, continued its partnership with the Paradigm for Parity Coalition, was a signatory of the Race at Work Charter, and was a Stonewall diversity champion in the U.K.
    Unum's 2022 ESG Report includes a Task Force on Climate-Related Financial Disclosures (TCFD) report that highlights the risks and opportunities companies face because of climate change.

Anjuna Achieves AWS Security Competency Status

Retrieved on: 
Wednesday, April 26, 2023

PALO ALTO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Anjuna Security Inc., a confidential computing software company, today announced it has successfully achieved AWS Security Competency Status.

Key Points: 
  • PALO ALTO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Anjuna Security Inc., a confidential computing software company, today announced it has successfully achieved AWS Security Competency Status.
  • The AWS Competency Program validates and promotes AWS Partners with demonstrated AWS technical expertise and proven customer success.
  • We are proud to achieve the AWS Security Competency.”
    With Anjuna, organizations can unlock the power of confidential computing on AWS Nitro Enclaves without the need for complex code change.
  • Anjuna’s technology is currently available to all AWS customers, and can be purchased by contacting Anjuna sales, authorized reseller partners, or in AWS Marketplace.

First Light Field-Enabled Spine Surgery Navigation Platform, Proprio Paradigm™, Receives FDA Clearance

Retrieved on: 
Tuesday, April 25, 2023

SEATTLE, April 25, 2023 /PRNewswire/ -- Proprio, a Seattle-based medical technology company, today announced its surgical navigation platform, Paradigm, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Paradigm utilizes an advanced approach to replace traditional surgical navigation technologies that pull attention away from the patient and disrupt workflows in the process.

Key Points: 
  • SEATTLE, April 25, 2023 /PRNewswire/ -- Proprio , a Seattle-based medical technology company, today announced its surgical navigation platform, Paradigm, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
  • Proprio's Paradigm platform is the first to use light field technology in spine surgery navigation to create a real-time 3D view of anatomy and the surgical scene.
  • "We are very enthusiastic about the potential for Paradigm to enable clinicians to revolutionize spine surgery," said Gabriel Jones, CEO and Co-Founder of Proprio.
  • Traditional surgical navigation systems collect very little intraoperative data," said Dr. Samuel Browd, CMO and Co-Founder of Proprio.

Broad Street Development Launches Paradigm Advisory Group to Preserve, Enhance Real Estate Value for Lenders, Special Servicers and Borrowers

Retrieved on: 
Monday, April 17, 2023

NEW YORK, April 17, 2023 /PRNewswire/ -- Broad Street Development LLC (BSD), a vertically integrated owner-operator, launched a new consulting arm to their company, Paradigm Advisory Group, founded by BSD principals Raymond Chalme and Daniel Blanco. Paradigm protects and enhances the value of distressed real estate assets on behalf of lenders, borrowers and special servicers. Paradigm's team, with decades of construction, leasing, restructuring, conversion, property management and marketing experience, will stabilize and preserve the value of New York City assets caught up in the challenging interest rate environment coupled with increased capital costs and declining operating fundamentals.

Key Points: 
  • Paradigm protects and enhances the value of distressed real estate assets on behalf of lenders, borrowers and special servicers.
  • Paradigm provides value-added asset management, construction, property management and leasing in both the office and residential sectors.
  • "This year alone we expect to see $30 billion of loans maturing on office property in New York.
  • The goal is to maximize value," said David Israni, Senior Managing Director of Asset Management for BSD.

Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up

Retrieved on: 
Tuesday, April 11, 2023

In October 2022, Paradigm said its phase 2 clinical study met its primary endpoint of a change from baseline to day 56 in one or more osteoarthritis disease biomarkers in synovial fluid.

Key Points: 
  • In October 2022, Paradigm said its phase 2 clinical study met its primary endpoint of a change from baseline to day 56 in one or more osteoarthritis disease biomarkers in synovial fluid.
  • The change from baseline to day 56 for pain and function are the approved endpoints in Paradigm’s 300-patient global phase 3 trial currently recruiting in the US, Europe and Australia.
  • There are currently no approved treatments for knee osteoarthritis that stop or slow the disease.
  • The exploratory 61-patient phase 2 randomised, double blind, placebo-controlled trial of iPPS for synovial biomarkers in knee osteoarthritis showed changes consistent with disease modifying efficacy in subjects with moderate to severe osteoarthritis.

Goldman Sachs One Million Black Women Deploys More Than $2.1 Billion, Expected to Impact the Lives of Over 215,000 Black Women Across the Country

Retrieved on: 
Monday, April 3, 2023

“Our firm has a long history of supporting economic empowerment, and we’re proud that One Million Black Women is already making a difference.”

Key Points: 
  • “Our firm has a long history of supporting economic empowerment, and we’re proud that One Million Black Women is already making a difference.”
    Over the last two years, Goldman Sachs has heard directly from over 20,000 Black women across the country through more than 60 listening sessions.
  • “I continue to believe that One Million Black Women will be a transformative initiative for driving long-term, systemic change.
  • “The purpose of SIB Expo is to celebrate and educate women of color entrepreneurs — a mission which perfectly dovetails with the goals of One Million Black Women.
  • One Million Black Women embodies our motto “When my Sistah wins, we all win®️”.

Book Release: Jennifer Wines is Bringing Visibility to "INVISIBLE WEALTH"

Retrieved on: 
Wednesday, April 12, 2023

This timely read presents a striking new concept and framework for redefining wealth.

Key Points: 
  • This timely read presents a striking new concept and framework for redefining wealth.
  • "Invisible Wealth" explores the technological advancements and societal shifts that have us valuing everything from digital assets to digital community.
  • Wines says, "We're in the midst of a paradigm shift, redefining what we value and by extension redefining our concept of wealth.
  • Wiley is publishing and distributing the book through all major bookstores and online retailers.

Wildcard Announces Their Genesis Mint Happening on Magic Eden on April 20

Retrieved on: 
Tuesday, April 4, 2023

MCKINNEY, Texas, April 4, 2023 /PRNewswire/ -- Wildcard's Genesis WildPass Mint launches on April 20 through an exclusive partnership with Magic Eden. The mint will consist of 4,444 WildPasses on the Polygon blockchain network, providing exclusive opportunities and access to the Wildcard Universe. The Genesis WildPass is the key that unlocks the door to the Wildcard Web3 ecosystem and it will be available on Magic Eden's Launchpad platform on April 20.

Key Points: 
  • MCKINNEY, Texas, April 4, 2023 /PRNewswire/ -- Wildcard's Genesis WildPass Mint launches on April 20 through an exclusive partnership with Magic Eden.
  • The mint will consist of 4,444 WildPasses on the Polygon blockchain network, providing exclusive opportunities and access to the Wildcard Universe.
  • The Genesis WildPass is the key that unlocks the door to the Wildcard Web3 ecosystem and it will be available on Magic Eden's Launchpad platform on April 20.
  • To learn more about the Wildcard Genesis WildPass Mint, click here .

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

Retrieved on: 
Wednesday, March 8, 2023

BEDFORD, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it is highlighting recently-launched products in high growth segments of joint preservation and restoration at the 2023 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting on March 8-10 in Las Vegas, NV. Throughout the event, Anika will feature the X-Twist Fixation System, the OVOMotion with Inlay Glenoid Total Shoulder Arthroplasty (TSA) System, and Tactoset Injectable Bone Substitute, among its other early intervention orthopedic solutions, in booth #3214.

Key Points: 
  • Furthermore, we continue to bring meaningful new products to market, such as the recent limited market release of our RevoMotion Reverse Shoulder System.
  • These devices are meaningful advancements for surgeons and their patients.”
    Dr. Blanchard continued, “The limited launch of RevoMotion is a significant step forward as Anika builds on the strong foundation for our multi-year growth strategy in joint preservation.
  • This cornerstone system affords surgeons a variety of knotless and knotted soft tissue fixation options in a single anchor platform.
  • Key benefits of RevoMotion include:
    RevoMotion will be shown during the AAOS at the Anika booth by appointment only due to its limited market release status.